Faculty of Humanities and Arts, Macau University of Science and Technology, Taipa, Macau SAR, China.
State Key Laboratory of Quality Research in Chinese Medicines, Macau University of Science and Technology, Taipa, Macau SAR, China.
Front Public Health. 2024 Oct 8;12:1420933. doi: 10.3389/fpubh.2024.1420933. eCollection 2024.
Lung cancer remains the leading cause of cancer-related mortality globally, with environmental pollutants identified as significant risk factors, especially for nonsmokers. The intersection of these pollutants with epigenetic mechanisms has emerged as a critical area of interest for understanding the etiology and progression of lung cancer. Epigenetic changes, including DNA methylation, histone modifications, and non-coding RNAs, can induce alterations in gene expression without affecting the DNA sequence and are influenced by environmental factors, contributing to the transformation of normal cells into malignant cells. This review assessed the literature on the influence of environmental pollutants on lung cancer epigenetics. A comprehensive search across databases such as PubMed, Web of Science, Cochrane Library, and Embase yielded 3,254 publications, with 22 high-quality papers included for in-depth analysis. These studies demonstrated the role of epigenetic markers, such as DNA methylation patterns of genes like F2RL3 and AHRR and alterations in the miRNA expression profiles, as potential biomarkers for lung cancer diagnosis and treatment. The review highlights the need to expand research beyond homogenous adult male groups typically found in high-risk occupational environments to broader population demographics. Such diversification can reduce biases and enhance the relevance of findings to various clinical contexts, fostering the development of personalized preventive and therapeutic measures. In conclusion, our findings underscore the potential of innovative epigenetic therapies, such as DNA demethylating drugs and histone modification agents, to counter environmental toxins' carcinogenic effects. The growing interest in miRNA therapies and studies aiming to correct aberrant methylation patterns indicate significant strides toward better lung cancer management and a healthier future for global communities.
肺癌仍然是全球癌症相关死亡的主要原因,环境污染物被确定为重要的风险因素,尤其是对于不吸烟者。这些污染物与表观遗传机制的交叉点已成为理解肺癌病因和进展的一个关键研究领域。表观遗传变化,包括 DNA 甲基化、组蛋白修饰和非编码 RNA,可以在不影响 DNA 序列的情况下诱导基因表达的改变,并且受到环境因素的影响,导致正常细胞转化为恶性细胞。本综述评估了环境污染物对肺癌表观遗传学的影响。通过对 PubMed、Web of Science、Cochrane Library 和 Embase 等数据库进行全面搜索,共获得 3254 篇出版物,其中有 22 篇高质量论文被纳入深入分析。这些研究表明,表观遗传标记物(如 F2RL3 和 AHRR 等基因的 DNA 甲基化模式以及 miRNA 表达谱的改变)作为肺癌诊断和治疗的潜在生物标志物的作用。该综述强调了需要将研究扩展到通常在高风险职业环境中发现的同质成年男性群体之外,涵盖更广泛的人口统计学特征。这种多样化可以减少偏见,提高研究结果对各种临床环境的相关性,促进针对特定人群的预防和治疗措施的发展。总之,我们的研究结果强调了创新的表观遗传疗法(如 DNA 去甲基化药物和组蛋白修饰剂)在对抗环境毒素致癌作用方面的潜力。对 miRNA 疗法的日益关注以及旨在纠正异常甲基化模式的研究表明,在改善肺癌管理和为全球社区创造更健康的未来方面取得了重大进展。